These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 16313349)

  • 1. Interplay between interferon and other cytokine systems in bone metabolism.
    Takayanagi H; Sato K; Takaoka A; Taniguchi T
    Immunol Rev; 2005 Dec; 208():181-93. PubMed ID: 16313349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects of treatment using interferon for bone diseases].
    Iba K; Takada J; Yamashita T
    Nihon Rinsho; 2006 Jul; 64(7):1275-80. PubMed ID: 16838644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
    Takayanagi H; Ogasawara K; Hida S; Chiba T; Murata S; Sato K; Takaoka A; Yokochi T; Oda H; Tanaka K; Nakamura K; Taniguchi T
    Nature; 2000 Nov; 408(6812):600-5. PubMed ID: 11117749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat1-mediated cytoplasmic attenuation in osteoimmunology.
    Takayanagi H; Kim S; Koga T; Taniguchi T
    J Cell Biochem; 2005 Feb; 94(2):232-40. PubMed ID: 15546140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bone destruction and osteoimmunology.
    Takayanagi H
    J Periodontal Res; 2005 Aug; 40(4):287-93. PubMed ID: 15966905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.
    Takayanagi H; Kim S; Matsuo K; Suzuki H; Suzuki T; Sato K; Yokochi T; Oda H; Nakamura K; Ida N; Wagner EF; Taniguchi T
    Nature; 2002 Apr; 416(6882):744-9. PubMed ID: 11961557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulatory mechanism of bone resorption: roles of bone remodeling-regulatory cytokines 'osteokines' in osteoclast differentiation and function].
    Kobayashi Y; Takahashi N
    Nihon Rinsho; 2003 Feb; 61(2):200-6. PubMed ID: 12638208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatic diseases: the effects of inflammation on bone.
    Walsh NC; Crotti TN; Goldring SR; Gravallese EM
    Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.
    Wada T; Nakashima T; Oliveira-dos-Santos AJ; Gasser J; Hara H; Schett G; Penninger JM
    Nat Med; 2005 Apr; 11(4):394-9. PubMed ID: 15750601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
    Sato K; Takayanagi H
    Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
    Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR
    Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling crosstalk between RANKL and interferons in osteoclast differentiation.
    Takayanagi H; Kim S; Taniguchi T
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S227-32. PubMed ID: 12110142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular interactions between immune system and bone.
    Grcević D; Katavić V; Lukić IK; Kovacić N; Lorenzo JA; Marusić A
    Croat Med J; 2001 Aug; 42(4):384-92. PubMed ID: 11471190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast precursors, RANKL/RANK, and immunology.
    Xing L; Schwarz EM; Boyce BF
    Immunol Rev; 2005 Dec; 208():19-29. PubMed ID: 16313338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL.
    Kotake S; Nanke Y; Mogi M; Kawamoto M; Furuya T; Yago T; Kobashigawa T; Togari A; Kamatani N
    Eur J Immunol; 2005 Nov; 35(11):3353-63. PubMed ID: 16220542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL-RANK signaling in osteoclastogenesis and bone disease.
    Wada T; Nakashima T; Hiroshi N; Penninger JM
    Trends Mol Med; 2006 Jan; 12(1):17-25. PubMed ID: 16356770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL signaling in bone physiology and cancer.
    Dougall WC
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):317-22. PubMed ID: 18685382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
    Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
    Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKing intracellular signaling in osteoclasts.
    Feng X
    IUBMB Life; 2005 Jun; 57(6):389-95. PubMed ID: 16012047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis.
    Udagawa N
    J Bone Miner Metab; 2003; 21(6):337-43. PubMed ID: 14586789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.